Merit Medical Showcases Innovations at CIRSE Annual Congress
Merit Medical Showcases Innovations at CIRSE Annual Congress
Merit Medical Systems, Inc. (NASDAQ: MMSI) is gearing up for a significant presence at the upcoming CIRSE Annual Congress, a key event for healthcare professionals focusing on cardiovascular and interventional radiology. The congress, held in Lisbon, Portugal, will provide an excellent platform for sharing groundbreaking research and advancements in the medical field.
Highlights from the Presentations
During the congress, clinicians affiliated with Merit Medical will present vital updates on two pivotal studies: the WAVE study and the MOTION study. These presentations are scheduled for September 14, showcasing 6-month clinical outcomes from the WAVE study during a dedicated session. This session, called FIRST@CIRSE Clinical Trial, will occur between 11:30 and 12:30, bringing together medical professionals eager to learn more about the findings.
Overview of Key Studies
Additionally, the session entitled “Meet the Brains Behind These Landmark Trials,” set between 13:00 and 14:00, will delve into the design and methodology of the MOTION study. This is an exciting opportunity for attendees to gain insights into the innovative strategies being employed to enhance patient outcomes in interventional radiology.
Sponsored Symposia at CIRSE
Merit Medical is not only presenting research but is also proud to sponsor two significant symposia at the congress. The first symposium, happening on September 15 in Auditorium 2 from 11:30 to 12:30, will focus on treating synovial arterial hypervascularity in the knee, discussing current evidence and management strategies. Following this, on September 16 in Auditorium 7 from 13:00 to 14:00, the second symposium will concentrate on maintaining long-term patency for patients undergoing hemodialysis.
Connecting with Healthcare Professionals
Fred Lampropoulos, the Chairman and CEO of Merit Medical, expressed the company's enthusiasm for participating in the CIRSE Annual Congress. He stated, “We are honored to attend CIRSE, connect with our physician partners, and all interventional radiologists who will attend the conference.” This sentiment reflects the company's commitment to advancing medical knowledge and fostering relationships within the healthcare community.
Accessing Symposium Content
For those unable to attend in person, it has been announced that the symposia will be accessible through a complimentary myCIRSE account, allowing anyone to engage with the sessions live or on-demand shortly after they conclude. This ensures that valuable information is shared widely, particularly amongst professionals unable to travel to the event.
About Merit Medical
Founded in 1987, Merit Medical Systems, Inc. has established itself as a leader in the development and distribution of innovative medical devices. These proprietary disposable devices are integral in various interventional, diagnostic, and therapeutic procedures across fields such as cardiology, endoscopy, and oncology. With a dedicated team of over 7,100 employees, Merit Medical services a global clientele, ensuring the provision of high-quality medical products and support.
Frequently Asked Questions
What is the CIRSE Annual Congress?
The CIRSE Annual Congress is a premier event in the field of interventional radiology, bringing together healthcare professionals worldwide to share knowledge and advancements.
What studies will Merit Medical present?
Merit Medical will present updates from the WAVE study and the MOTION study, focusing on clinical outcomes and trial methodologies, respectively.
How can professionals access the symposia?
Symposium content can be accessed via a free myCIRSE account, enabling both live viewing and on-demand access post-event.
What are the main topics of the sponsored symposia?
The first symposium will focus on the treatment of synovial arterial hypervascularity in the knee, while the second will address strategies for maintaining long-term patency for hemodialysis patients.
Who is the CEO of Merit Medical?
Fred Lampropoulos serves as the Chairman and Chief Executive Officer of Merit Medical Systems, Inc.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.